10.1016/j.neulet.2014.12.053 Neurosci
On January 30, China's National Medical Products Administration approved Sciwind Biosciences' ecnoglutide injection, marketed as Xianyida, for adults with type 2 diabetes
A., Ranasinghe, P., & Block, L
Changes in vision require prompt attention, particularly if you have diabetes, as semaglutide has been associated with worsening of diabetic retinopathy in some patients with type 2 diabetes, as noted in the SmPC
Any therapy whether its a supplement, an over-the-counter medication, or even if its described as all natural can cause side effects and could interact with prescription drugs
Rapid economic development and urbanization have contributed to this rising burden